“The tool molecule has the same CD3 binding arm but different GPRC5D binding arm as talquetamab, and binding and in vitro functional activity against cGPRC5D-expressing cells consistent with talquetamab against hGPRC5D-expressing cells.”
✓ VerifiedFDA multi-discipline review, p. 55Source ↗